FrieslandCampina, Glycosyn to partner

17 Feb 2016

FrieslandCampina Domo and US-based Glycosyn are creating a global partnership to develop new infant nutrition ingredients. Glycosyn has developed a patented technology for the production of oligosaccharides from lactose.

FrieslandCampina, Glycosyn to partner

FrieslandCampina Domo and US-based Glycosyn are creating a global partnership to develop new infant nutrition ingredients, having signed a technology and partnership agreement. Glycosyn has developed a patented technology for the production of oligosaccharides from lactose. FrieslandCampina Domo will produce and introduce these new ingredients onto the global market.

“Human Milk Oligosaccharides (HMOs) are specialised carbohydrates which are naturally prevalent in mother’s milk,” said John R. Garrett, co-CEO at Glycosyn. “Through our expertise and know-how we have developed technologies which will complement FrieslandCampina’s extensive history and knowledge of infant nutrition ingredients, products and markets.”

“Glycosyn helps us to take a very exciting step towards developing the next generation of infant nutrition and to strengthen our position as a market leader in infant nutrition ingredients,” said Tine Snels, Executive Director of FrieslandCampina Ingredients. “We are doing this to meet the growing global demand for high-quality ingredients. Our cooperation is a perfect example of co-creation. The first quantities for trials will be available in the current year.”